Snedkova L V, Vasiuk V K, Fursov G G, Panteleeva G P
Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(10):35-9.
26 patients with affective and schizoaffective psychoses either therapeutically resistant to lithium salts or with intolerance to them were treated. Control period of preventive therapy (lithium carbonate in average doses O.6-O.9 g daily) and experimental period (nifedipine, average doses 30-40 mg daily) were equal in duration, 2 years exactly. Preventive effect of nifedipine exceeded the same effect of lithium carbonate in 65.4% of patients. The total duration of affective attacks in the experimental period was reduced on 46.8% and their frequency-on 31.7% in comparison with the control period. A number of hospital admissions decreased (on 52.2%) with a simultaneous tendency to transition of a disease to a more light level (a number of attacks of cyclothymic level increased on 17.3%). The data gives ground for the perspectives of application of nifedipine in the cases of insufficient prophylactic effect or intolerance to lithium salts.
对26例情感性和分裂情感性精神病患者进行了治疗,这些患者要么对锂盐治疗耐药,要么对其不耐受。预防性治疗的对照期(平均每日剂量0.6 - 0.9克碳酸锂)和实验期(硝苯地平,平均每日剂量30 - 40毫克)持续时间相等,恰好为2年。在65.4%的患者中,硝苯地平的预防效果超过了碳酸锂的相同效果。与对照期相比,实验期情感发作的总持续时间减少了46.8%,发作频率减少了31.7%。住院次数减少了(52.2%),同时疾病有向较轻程度转变的趋势(环性心境水平发作次数增加了17.3%)。这些数据为硝苯地平在预防效果不足或对锂盐不耐受的情况下的应用前景提供了依据。